PPTA Twitter

PlasmaProteins
PlasmaProteins Stay in the know and get connected on all @PlasmaProteins channels. Find us on... Facebook: bit.ly/2KOn6sh LinkedIn: bit.ly/31Y1nnn
About 18 hours ago.
PlasmaProteins
PlasmaProteins Your #plasmadonation can make a difference in the lives of those living with rare conditions such as #hemophilia or alpha-1 antitrypsin deficiency, both of which can be treated with #plasmaprotein therapies. Learn more about why your donation matters: bit.ly/2kx5I0P
4 days ago.

Public Workshop Focuses on Immune Globulin Products

On Nov. 8-9, the U.S. Food and Drug Administration (FDA) is conducting a public workshop entitled "Immune Globulin Potency in the 21st Century." The purpose of the public workshop is to discuss new challenges to meet U.S. potency requirements for Immune Globulin (IG) products and to identify measures to address these challenges.

The workshop has been planned in partnership with the Immune Deficiency Foundation (IDF) and the Plasma Protein Therapeutics Association (PPTA). The workshop will include presentations and panel discussions by experts from academic institutions, industry, and government agencies.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100